SG Americas Securities LLC lifted its holdings in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 151.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 37,684 shares of the health services provider's stock after purchasing an additional 22,671 shares during the quarter. SG Americas Securities LLC's holdings in Select Medical were worth $629,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Smartleaf Asset Management LLC boosted its stake in Select Medical by 179.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock valued at $43,000 after buying an additional 1,473 shares in the last quarter. Covestor Ltd boosted its stake in Select Medical by 33.5% during the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock valued at $93,000 after buying an additional 1,244 shares in the last quarter. GAMMA Investing LLC boosted its stake in Select Medical by 217.4% during the first quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock valued at $109,000 after buying an additional 4,453 shares in the last quarter. Lazard Asset Management LLC boosted its stake in Select Medical by 47.8% during the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after buying an additional 2,255 shares in the last quarter. Finally, Quarry LP boosted its position in shares of Select Medical by 963.0% in the 4th quarter. Quarry LP now owns 9,078 shares of the health services provider's stock valued at $171,000 after purchasing an additional 8,224 shares during the period. Institutional investors own 89.48% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the company. Mizuho assumed coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 price target on the stock. Benchmark raised Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a research note on Monday, February 24th. Finally, Royal Bank Of Canada dropped their price target on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 7th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, Select Medical currently has a consensus rating of "Moderate Buy" and an average price target of $26.00.
Check Out Our Latest Report on Select Medical
Select Medical Stock Down 0.6%
NYSE:SEM traded down $0.10 on Friday, hitting $14.83. 1,972,688 shares of the company's stock traded hands, compared to its average volume of 970,753. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.87. Select Medical Holdings Corporation has a 1 year low of $14.03 and a 1 year high of $40.98. The firm has a 50-day moving average price of $15.52 and a 200-day moving average price of $17.36. The company has a market cap of $1.91 billion, a PE ratio of 11.06, a price-to-earnings-growth ratio of 0.79 and a beta of 1.34.
Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.01). Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the prior year, the firm earned $0.75 earnings per share. The firm's quarterly revenue was down 24.4% compared to the same quarter last year. Equities analysts anticipate that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.
Select Medical Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a $0.0625 dividend. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.25 annualized dividend and a yield of 1.69%. Select Medical's dividend payout ratio (DPR) is currently 18.66%.
Select Medical announced that its board has initiated a share repurchase plan on Thursday, May 1st that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the health services provider to purchase up to 42.6% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's management believes its stock is undervalued.
Insider Buying and Selling
In other Select Medical news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the company's stock in a transaction on Monday, May 5th. The shares were bought at an average cost of $15.02 per share, with a total value of $315,420.00. Following the transaction, the director now directly owns 65,089 shares in the company, valued at approximately $977,636.78. This represents a 47.63% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO David S. Chernow sold 225,000 shares of Select Medical stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the transaction, the chief executive officer now directly owns 714,516 shares in the company, valued at approximately $12,861,288. This represents a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.60% of the company's stock.
About Select Medical
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.